Antineoplastic / Chemotherapeutic agent / Anthracyclines

Pemetrexed is an antineoplastic chemotherapy drug. It is used in the treatment of malignant mesothelioma and locally advanced or metastatic nonsquamous non-small cell lung cancer. - Available as a ready to dilute liquid formulation - does not require reconstitution from powder saving time and costs. It can...

We offer a wide range of API products which includes Docetaxel anhydrous. It belongs to oncology category. Therapeutic category: antineoplastic. 

Other products:Amisulpride，Desvenlafaxine Succinate，Neostigmine methylsulfate
Teicoplanin，Daptomycin，Minocycline HCl，Vancomycin HCl, Levofloxacin...

intermediates

ChetoSensar™ is our novel solubilization technology for hydrophobic ADCs.

Increased ADC solubility, important for reaching high DARWider therapeutic index and higher drug efficacyImproved bioconjugation efficiencyChetoSensar™ and ready-to-conjugate drug linkers available as samples or within ADC...

50mg daily: Combination with luteinizing hormone releasing hormone (LHRH) analogs or surgical orchiectomy for the treatment of advanced prostatic carcinoma.

150mg daily: For the treatment of patients with locally advanced prostate cancer without distant metastasis, who are unsuitable or unwillin...

• Genexol®PM Inj.(Paclitaxel)   • Genexol® Inj.(Paclitaxel) • Nanoxel®M Inj.(Docetaxel) • Docetaxel Inj.(Docetaxel) • Nexatin® Inj.(Oxaliplatin) • Everose® Tab.(Everolimus) • Pemed®S Inj.(Pemetrexed) • Azalid® Inj.(Azacitidine) • Decilid® Inj.(Decitabine) • Lenalid® Inj.(Lenalid...

ARaymondlife has developed the essential accessory for drug reconstitution, the vial adapter, one for each RayDyLyo diameter. The RayDyLyo® vial adapter is a medical device intended for the quick and safe reconstitution of drugs, contained in vials capped with RayDyLyo® plastic press fit caps, a...

Oncology drugs/adjuvant antitumor drugs.CAS NO.24584-09-6,
Standard: In-house

It is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma

Indicated, in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation chemotherapy, for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who are FLT3 mutation-positive, as detected by a FDA approved test

Oxaliplatinis a cancer medication used to treat colorectal cancer. Often it is used together with fluorouracil and folinic acid (leucovorin) in advanced cancer.

For more information about our made in Germany product, please contact us. pharma@axxo.de
...

A niche oncology API used for the treatment of multiple myeloma and ovarian cancer. Melphalan HCl Injection, at high intravenous dosage, is indicated, with or without haematopoietic stem cell transplantation, for the treatment of multiple myeloma and childhood neuroblastoma. Available for all global mar...

Vial ampoule of freeze dried powder containing Bortezomib 3.5 mg for IV injection

Paclitaxel belongs to the category of chemotherapeutic agents and is utilized as a treatment for various types of cancer. Indications for using paclitaxel encompass a range of cancers, including breast, ovarian, bladder, lung, prostate, melanoma, esophageal, Kaposi sarcoma, and various other solid tumors.

Prostatic Neoplasms

Silver Sulphadiazine use to prevent and treat wound infections in patients with second- and third-degree burns.

We have WHO GMP & WC for this product 

Heraeus Precious Metals business line Pharmaceutical Ingredients provides a wide range of active pharmaceutical ingredients, which includes Carboplatin. Contact us for more information.

Protein-bound paclitaxel, also known as nanoparticle albumin–bound paclitaxel or nab-paclitaxel, is an injectable formulation of paclitaxel used to treat breast cancer, lung cancer and pancreatic cancer, among others.

With US and EU GMPApproved and sold in US and EU.

Generic Name: Trabectedin lyophilized powder
Indication: Treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen.
Originator: Pharma Mar
Approval: US: Oct. 2015 (Janssen) 
Exclusivity: ODE-100 04/23